At the beginning of the coronavirus pandemic, Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), dramatically told a G20 Leaders’ Summit that “we are at war with a virus that threatens to tear us apart.” At the same meeting, António Guterres, UN General Secretary, said “we are at war with a […]
On 2nd December, the UK became the first country in the world to approve the Pfizer/BioNTech COVID-19 vaccine, following review by the MHRA. This announcement comes a ground-breaking seven months after the start of clinical trials and marks a major breakthrough, but it’s clear that the COVID-19 pandemic is far from over. Recent criticism that […]
Nowadays it is common practice to dismiss and even condemn people when their beliefs do not align with ours. When news began to circulate that ‘up to a third of people’ in the UK may refuse a coronavirus vaccine, based on a YouGov report of 1,663 adults, it was easy to blame this on anti-vaxxers. […]
With unprecedented speed, the UK has become the first country to approve emergency use authorization for a COVID-19 vaccine that has been tested in a large-scale clinical trial.1 While this is a welcome milestone, it is important to remember that, as the vaccine is rolled out to millions of people, scientists and the public still […]
The pandemic in which we are currently living has seen many of us just about surviving, and certainly not thriving. The impact of COVID-19 has been far reaching and touched upon every aspect of our lives; the way we work, the way we socialize, the way we interact with our families. Unsurprisingly, there is a […]
The financial impact of the COVID-19 pandemic presents a potential risk to the future of clinical trials in rare diseases. Rare diseases by their nature are not very prevalent in the population, therefore, any treatment for a rare disease will only have a small number of beneficiaries. In addition, so-called orphan drug development takes around 18% […]
As COVID-19 continues to spread across the U.S., its impact on the U.S. health system is without precedent, with direct and indirect medical costs estimated to be in the hundreds of billions of dollars. On an individual basis, cost estimates from the Peterson Center on Healthcare and Kaiser Family Foundation (KFF) range from between $10,000 to […]
We have seen a digital revolution sweep across clinical practice, driven by the extraordinary circumstances of the coronavirus.
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
Telehealth, in particular, has been waiting for its moment. In the U.S., the first recorded instance of telemedicine happened more than 60 years ago (!) when the Nebraska Psychiatry Institute began using closed-circuit TV for psychiatric consultations.